Spinal Cord Tumors
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma (NCT00826241) | National Institutes of Health Clinical Center (CC) | 2009-01-01 |
Track Spinal Cord Tumors automatically
Every clearance here is in the API, with alerts when new ones post.